RegenEra Logo

Building on the breakthrough discoveries of ageing biology and AI, we create exceptional value and shared success utilising our deep scientific and industry networks.

About RegenEra Ventures

RegenEra Ventures is a global VC fund focusing on early-stage biotech companies in the field of regenerative medicine and diseases of ageing. Founded in 2025, we combine a strong industry network with an experienced investment team and scientific expertise.

Our Mission

We bridge the gap between innovative research and clinical validation, providing capital and expertise to accelerate breakthrough therapies to market.

Our Focus

We operate globally with primary focus on the US, Europe & APAC, as a lead/co-lead investor for Seed to Series A companies with a science-driven approach.

Investment Focus

RegenEra bridges the gap between innovative research and clinical validation in regenerative medicine and longevity therapeutics.

Therapies

Novel therapeutics targeting cellular aging mechanisms and regenerative pathways.

Medical Devices

Innovative devices and delivery platforms for regenerative therapies.

Invest in the Future of Longevity

Longevity represents a transformative investment frontier, impacting every facet of life and demanding innovative solutions. RegenEra Ventures is positioned at the forefront of this revolution, backing visionary founders building the future of healthspan.

We partner with qualified investors who share our vision and commitment to advancing regenerative medicine and tackling diseases of ageing.

For further information on investment opportunities, please reach out to us:

investors@regeneravc.com

Contact Us

We're interested in speaking with founders and researchers in regenerative medicine and longevity.

Max file size: 10MB. Accepted types: PDF, DOC(X), JPG, PNG, WEBP.

Or email us directly at:

info@regeneravc.com